Role of adjuvant surgery for patients with initially unresectable pancreatic cancer with a long-term favorable response to non-surgical anti-cancer treatments: results of a project study for pancreatic surgery by the Japanese Society of Hepato-Biliary-Pan-Reference-Cited by-同舟云学术

Role of adjuvant surgery for patients with initially unresectable pancreatic cancer with a long-term favorable response to non-surgical anti-cancer treatments: results of a project study for pancreatic surgery by the Japanese Society of Hepato-Biliary-Pan

Published:2013-05-10 Issue:6 Volume:20 Page:590-600
ISSN:1868-6974
Container-title:Journal of Hepato-Biliary-Pancreatic Sciences
language:en
Short-container-title:Journal of Hepato-Biliary-Pancreatic Sciences

Author:

Satoi Sohei¹,Yamaue Hiroki²,Kato Kentaro³,Takahashi Shinichiro⁴,Hirono Seiko²,Takeda Shin⁵,Eguchi Hidetoshi⁶,Sho Masayuki⁷,Wada Keita⁸,Shinchi Hiroyuki⁹,Kwon A. Hon¹,Hirano Satoshi³,Kinoshita Taira⁴,Nakao Akimasa⁵,Nagano Hiroaki⁶,Nakajima Yoshiyuki⁷,Sano Keiji⁸,Miyazaki Masaru¹⁰,Takada Tadahiro¹¹

Affiliation:

1. Department of Surgery; Kansai Medical University; Moriguchi Japan

2. Second Department of Surgery; Wakayama Medical University School of Medicine; Wakayama Japan

3. Department of Surgical Oncology; Hokkaido University Graduate School of Medicine; Sapporo Japan

4. Department of Hepatobiliary Pancreatic Surgery; National Cancer Center Hospital East; Kashiwa Japan

5. Department of Gastroenterological Surgery (Surgery II); Nagoya University Graduate School of Medicine; Nagoya Japan

6. Department of Surgery, Graduate School of Medicine; Osaka University; Suita Japan

7. Department of Surgery; Nara Medical University Graduate School of Medicine; Nara Japan

8. Department of Surgery; Teikyo University School of Medicine; Tokyo Japan

9. Department of Surgical Oncology; Kagoshima University; Kagoshima Japan

10. Department of General Surgery; Chiba University, Graduate School of Medicine; Chiba Japan

11. The Japanese Society of Hepato-Biliary-Pancreatic Surgery; Tokyo Japan

Publisher

Wiley

Subject

Hepatology,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s00534-013-0616-0

Reference29 articles.

1. Pancreatic carcinoma;Warshaw;N Engl J Med.,1992

2. Long-term survival after curative resection for pancreatic ductal adenocarcinoma: clinicopathological analysis of 5-year survivors;Conlon;Ann Surg.,1996

3. Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone;Gastrointestinal Tumor Study Group;J Natl Cancer Inst.,1988

4. A multi-institutional comparative trial of radiation therapy alone and in combination with 5-fluorouracil for locally unresectable pancreatic carcinoma;Gastrointestinal Tumor Study Group;Ann Surg.,1979

5. Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study;Chauffert;Ann Oncol.,2008

Cited by 155 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A case of metachronous oligo-hepatic and peritoneal metastases of pancreatic cancer with a favorable outcome after conversion surgery combined with perioperative sequential chemotherapy;Clinical Journal of Gastroenterology;2024-01-31

2. Conversion surgery for initially unresectable locally advanced pancreatic ductal adenocarcinoma after chemotherapy followed by carbon-ion radiotherapy: a case report;Journal of Medical Case Reports;2024-01-11

3. Oligo‐like liver metastasis: A novel prognostic indicator to improve survival in pancreatic cancer;Annals of Gastroenterological Surgery;2023-11-13

4. Pretherapeutic factors predicting conversion surgery in unresectable pancreatic ductal adenocarcinoma: a retrospective study;2023-10-06

5. Extrapancreatic extension is a better adverse prognostic factor than tumor size in patients with localized pancreatic ductal adenocarcinoma treated with chemoradiotherapy – comparison of T category between the American Joint Committee on Cancer and Japan Pancreas Society;HPB;2023-10